Matrix metalloproteinase-9-dependent exposure of a cryptic migratory control site in collagen is required before retinal angiogenesis

American Journal of Pathology

Volumn 161, Issue 4, 2002, Pages 1429-1437

  Hangai, Masanori ^a,b   Kitaya, Norihiko ^b   Xu, Jingsong ^c   Chan, Candy K ^b   Kim, Jenny J ^b   Werb, Zena ^d   Ryan, Stephen J ^b   Brooks, Peter C ^c  

^a KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN TYPE 4; GELATINASE A; GELATINASE B; MONOCLONAL ANTIBODY;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INTERACTION; CELL MIGRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; EXPOSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA; RETINA NEOVASCULARIZATION; VISUAL IMPAIRMENT;

EID: 0036791588     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64418-5     Document Type: Article

References (35)

1. Adamis AP, Aiello LP, D'Amato RA. Angiogenesis and ophthalmic disease. Angiogenesis 1999, 3:9-14
2. Campochiaro PA: Retinal and choroidal neovascularization. J Cell Physiol 2000, 18:301-310
3. Campochiaro PA, Soloway P, Ryan SJ, Miller JW: The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration. Mol Vis 1999, 5:34-38
4. Ozaki H, Seo MS, Ozaki K, Yamada E, Okamoto N, Hofmann F, Wood F, Campochiaro PA: Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol 2000, 156:697-707
5. Friedlander M, Brooks PC, Shaffer RW, Kincaid CM, Varner JA, Cheresh DA: Definition of two angiogenic pathways by distinct αv integrins. Science 1995, 270:1500-1502
6. Das A, McLamore A, Song W, McGuire PG: Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor. Arch Ophthamol 1999, 117:498-503
7. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000, 2:737-744
8. Smith LE, Shen W, Perruzzi C, Stoker S, Kinose F, Xu X, Robinson G, Driver S, Bischoff J, Zhang B, Schaeffer JM, Senger DR: Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor. Nat Med 1999, 5:1390-1395
9. Ferrar N, Alitalo K: Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 1999, 5:1359-1364
10. Brooks PC, Silletti S, von Schalscha TL, Friedlander M, Cheresh DA: Disruption of angiogenesis by PEX, a non catalytic metalloproteinase fragment with integrin binding activity Cell 1998, 92:1157-1164
11. Salzmann J, Limb GA, Khaw PT, Gregor ZJ, Webster L, Chignell AH, Charteris DG: Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol 2000, 84:1091-1096
12. Ozerdem U, Mach-Hofacre B, Chen L, Chaidhawangul S, Keefe K, McDermott CD, Bergeron-Lynn G, Appelt K, Freeman WR: The effect of prinomastat (AG3340), a potent inhibitor of matrix metalloproteinases, on a subacute model of proliferative vitroretinopathy. Curr Eye Res 2000, 6:447-453
13. Xu J, Rodriguez D, Kim JJ, Brooks PC: Generation of monoclonal antibodies to cryptic collagen sites by using subtractive immunization. Hybridoma 2000, 19:375-385
14. Xu J, Rodriguez D, Petitclerc E, Kim JJ, Hangai M, Moon YS, Davis GE, Brooks PC: Proteolytic exposure of a cryptic site within collagen type-IV is required for angiogenesis and tumor growth in vivo. J Cell Biol 2001, 154:1069-1079
15. Ljubimov AV, Burgeson RE, Butkowski RJ, Couchman JR, Zardi L, Ninomiya Y, Sado Y, Huang ZS, Nesgurn AB, Kenney MC: Basement membrane abnormalities in human eyes with diabetic retinopathy. J Histochem Cytochem 1996, 44:1469-1479
16. Spirin KS, Saghizadeh M, Lewin SL, Zardi L, Kenney MC, Ljubimov AV: Basement membrane and growth factor gene expression in normal and diabetic human retinas. Curr Eye Res 1999, 6:490-499
17. Kon CH, Asari RH, Occleston NL, Khaw PT, Aylward GW: A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1998, 8:1524-1629
18. Ozaki H, Okamoto N, Ortega S, Chang M, Ozaki K, Sadda S, Vinores MA, Derevjanik N, Zack DJ, Basilioco C, Campoichiaro PA: Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization. Am J Pathol 1998, 153:757-765
19. Tobe T, Ortega S, Luna JD, Ozaki H, Okamoto N, Derevjjanik NL, Vinores SA, Basilico C, Campochiaro PA: Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol 1998, 153:1641-1645
20. Smith LE, Wesolowski E, McLellan A, Kostyk SK, D'Amato R, Sullivan R, D'Amato PA: Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994, 35:101-111
21. Itoh T, Tanioka M, Yoshida T, Nishimoto H, Itohara S: Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 1998, 58:1048-1051
22. Vu TH, Shipley JM, Bergers G, Berges JE, Helms JA, Hanahan D, Sharpio SD, Senior RM, Werb Z: MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 1998, 93:411-422
23. Brooks PC, Strombald S, Sanders LC, von Schalscha TL, Aimes RT, Stetler-Stevenson WG, Quigley JP, Cheresh DA: Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 1996, 85:683-693
24. Brooks PC, Klemke RL, Schon S, Lewis JM, Schwartz MA, Cheresh DA: Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo. J Clin Invest 1997, 99:1390-1398
25. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z: Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999, 13:9-22
26. Suzuma K, Naruse K, Suzuman I, Akahara N, Ueki K, Aiello LP, King GL: Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1 and phosphatidylinositol 3-kinase-Akt-dependent pathways in retinal vascular cells. J Biol Chem 2000, 275:40725-40731
27. Rajotte D, Arap W, Hagedorn M, Koivunem E, Pasqualini R, Rouslahti E: Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J Clin Invest 1998, 102:430-437
28. St Croix B, Ragom C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW: Genes expressed in human tumor endothelium. Science 2000, 289:1197-1202
29. Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin HG: Heterogeneity of angiogenesis and blood vessel maturation in human tumor: implications for anti-angiogenic tumor therapies. Cancer Res 2000, 60:1388-1393
30. Vinores SA, Derevjanik NL, Vinores MA, Okamoto N, Campoichiaro PA: Sensitivity of different vascular beds in the eye to neovascularization and blood-retinal barrier breakdown in VEGF transgenic mice. Adv Exp Med Biol 2000, 476:129-138
31. Aird WC, Edelber JM, Weiler-Guettler H, Simmons WW, Smith TW, Rosenberg RD: Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment. J Cell Biol 1997, 138:1117-1124
32. Bader BL, Rayburn H, Crowley D, Hynes RO: Extensive vascularization, angiogenesis, organogenesis precede lethality in mice lacking all αv integrins. Cell 1998, 95:507-519
33. Petitclerc E, Stromblad S, von chalscha TL, Mitjans F, Piulats J, Montgomery AMP, Brooks PC: Integrin αvβ3 promotes M21 melanoma growth in human skin by regulating tumor cell survival. Cancer Res 1999, 59:2724-2730
34. Petitclerc E, Boutaud A, Prestakyo A, Xu J, Sado Y, Ninomiya Y, Sarras MP, Hudson BG, Brooks PC: New functions for noncollagenous domains of human collagen type-IV: novel integrin ligands inhibiting angiogenesis and tumor growth in vivo. J Biol Chem 2000, 275:8051-8061
35. Giannelli G, Flak-Marillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V: Induction of cell migration by matrix metalloprotinase-2 cleavage of laminin-5. Science 1997, 277:225-228